Yuviwel (navepegritide) Coverage Policy
Customize your policy alerts
Sign up for all Colorado Rocky Mountain Health Plans policy alerts
Know when Colorado Rocky Mountain Health Plans releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and reauthorization for Yuviwel (navepegritide) in pediatric patients with achondroplasia. Coverage applies to patients who meet age, open-epiphysis, diagnosis, clinical-response, and concomitant-therapy requirements.
Reauthorization criteria now require the patient to be younger than 18 years of age.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.